428 related articles for article (PubMed ID: 37164255)
1. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effect and component analysis of Chaihu Qingwen granules.
Zhou Y; Li QX; Liao ZZ; Liu Y; Ouyang Y; Jiang WJ; Tang MT; Hu JF; Zhang W
J Ethnopharmacol; 2023 Dec; 317():116763. PubMed ID: 37315646
[TBL] [Abstract][Full Text] [Related]
3. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
4. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats.
Wu Y; Huang D; Wang X; Pei C; Xiao W; Wang F; Wang Z
Int Immunopharmacol; 2021 Jul; 96():107621. PubMed ID: 33872850
[TBL] [Abstract][Full Text] [Related]
5. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
[TBL] [Abstract][Full Text] [Related]
7. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
8. Qinhuo Shanggan oral solution resolves acute lung injury by down-regulating TLR4/NF-
Tang S; Liang Y; Wang M; Lei J; Peng Y; Tao Q; Ming T; Yang W; Zhang C; Guo J; Xu H
Front Immunol; 2023; 14():1285550. PubMed ID: 37954597
[TBL] [Abstract][Full Text] [Related]
9. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
10. Protective Effects of
Shi K; Xiao Y; Dong Y; Wang D; Xie Y; Tu J; Xu K; Zhou Z; Cao G; Liu Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555773
[TBL] [Abstract][Full Text] [Related]
11. Fortunellin ameliorates LPS-induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF-κB/NLRP3 pathway.
Liu D; Guo R; Shi B; Chen M; Weng S; Weng J
Immun Inflamm Dis; 2024 Mar; 12(3):e1164. PubMed ID: 38501503
[TBL] [Abstract][Full Text] [Related]
12. Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway.
Zhu Y; Han Q; Wang L; Wang B; Chen J; Cai B; Wu C; Zhu X; Liu F; Han D; Dong H; Jia Y; Liu Y
J Ethnopharmacol; 2023 Jan; 301():115763. PubMed ID: 36183949
[TBL] [Abstract][Full Text] [Related]
13. Yemazhui () ameliorates lipopolysaccharide-induced acute lung injury modulation of the toll-like receptor 4/nuclear factor kappa-B/nod-like receptor family pyrin domain-containing 3 protein signaling pathway and intestinal flora in rats.
Li R; Yang H; Xue Y; Xianqin L
J Tradit Chin Med; 2024 Apr; 44(2):303-314. PubMed ID: 38504536
[TBL] [Abstract][Full Text] [Related]
14. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS
Zhang C; Wang X; Wang C; He C; Ma Q; Li J; Wang W; Xu YT; Wang T
Front Pharmacol; 2021; 12():790072. PubMed ID: 35002723
[No Abstract] [Full Text] [Related]
15. The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals.
Wang B; Wang J; Lu D; Qi N; Liu Q
J Invest Surg; 2021 Mar; 34(3):284-296. PubMed ID: 31274341
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydropalmatine induces the polarization of M1 macrophages to M2 to relieve limb ischemia-reperfusion-induced lung injury via inhibiting the TLR4/NF-κB/NLRP3 signaling pathway.
Wen H; Lu D; Chen H; Zhu Y; Xie Q; Zhang Z; Wu Z
Drug Dev Res; 2022 Sep; 83(6):1362-1372. PubMed ID: 35976115
[TBL] [Abstract][Full Text] [Related]
17. The involvement of oxidative stress and the TLR4/NF-κB/NLRP3 pathway in acute lung injury induced by high-altitude hypoxia.
Cao W; Zeng Y; Su Y; Gong H; He J; Liu Y; Li C
Immunobiology; 2024 May; 229(3):152809. PubMed ID: 38788361
[TBL] [Abstract][Full Text] [Related]
18. Exocarpium Citri Grandis ameliorates LPS-induced acute lung injury by suppressing inflammation, NLRP3 inflammasome, and ferroptosis.
Xu Z; Li J; Zhou K; Wang K; Hu H; Hu Y; Gao Y; Luo Z; Huang J
J Ethnopharmacol; 2024 Jul; 329():118162. PubMed ID: 38588989
[TBL] [Abstract][Full Text] [Related]
19. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
[TBL] [Abstract][Full Text] [Related]
20. Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-κB-NLRP3 Inflammasome Signaling Pathway.
Aydin P; Magden ZBA; Uzuncakmak SK; Halici H; Akgun N; Mendil AS; Mokhtare B; Cadirci E
Lung; 2022 Oct; 200(5):561-572. PubMed ID: 36040529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
